Clinical aspects of aldosterone and the «aldosterone escape » concept: what is the role of aldosterone receptor blockade?
Chairman:
Jonathan Elliott, UK
Questions and Answers
Chairman: Jonathan Elliot
Panel: Allan Struthers - Adrian Boswood - Clarke Atkins
Clinical trials, where are we 10 years after RALES study?
Chairman:
Jens Häggström, Sweden
Questions and Answers
Chairman: Jens Häggström
Panel: Faiez Zannad - Bertram Pitt - Michele Borgarelli